Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Anika Therapeutics disclosed the grant of 3,360 restricted stock units to one newly hired non-executive employee. The grant was made under the company’s 2021 Inducement Plan as a material inducement for employment, complying with Nasdaq Listing Rule 5635(c)(4).
Key figures
- Grant type
- RSUs
- Shares granted
- 3360
- Vesting schedule
- 3 equal installments over 3 years
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.